Home › Neuroblastoma › Massachusetts › Boston
Studi clinici su Neuroblastoma a Boston, MA
13 studi su Neuroblastoma cercano partecipanti presso sedi a Boston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
In reclutamentoFase 3
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
MCT for the Harvard/UCSF ROBIN Center
In reclutamento
- Brigham and Women's Hospital, Boston
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
In reclutamentoFase 1/2
- Dana-Farber Cancer Institute ( Site 1013), Boston
B7-H3.CD28Z.CART in Solid Tumors
In reclutamentoFase 1
- Dana Farber Cancer Institite, Boston
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
In reclutamentoFase 3
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
In reclutamentoFase 1/2
- Dana-Farber Cancer Institute, Boston
SPEARHEAD-3 Pediatric Study
In reclutamentoFase 1/2
- Dana Farber Cancer Institute, Boston
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
In reclutamentoFase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
In reclutamentoFase 2
- Boston Children's Hospital, Dana-Farber Cancer Institute., Boston
Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
In reclutamentoFase 1
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Neuroblastoma Biology Study
In reclutamentoStudio osservazionale
- Children's Hospital Boston, Boston
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
In reclutamento
- Dana-Farber Cancer Institute, Boston
Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
In reclutamentoFase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Studi su Neuroblastoma in altre città
- Washington, DC11 studi
- New York City, NY10 studi
- Dallas, TX9 studi
- Memphis, TN9 studi
- Philadelphia, PA9 studi
- St. Louis, MO9 studi
- Aurora, CO8 studi
- Hartford, CT8 studi
- Minneapolis, MN8 studi
- Birmingham, AL8 studi
- Atlanta, GA7 studi
- San Francisco, CA7 studi
Altri studi a Boston
- Cancro al seno111 studi
- Cancro del polmone non a piccole cellule90 studi
- Cancro (tutti i tipi)86 studi
- Cancro colorettale63 studi
- Cancro metastatico63 studi
- Cancro ai polmoni62 studi
- Cancro ovarico61 studi
- Cancro alla prostata59 studi
- Depressione52 studi
- Cancro dell'endometrio50 studi
- Insufficienza cardiaca44 studi
- Leucemia mieloide acuta44 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.